Various companies benefit from the biomedical profile of Campus Berlin-Buch. For example, Ascenion GmbH, a company specialized in the life sciences, provides support for public research institutions in the protection and exploitation of their intellectual property, advises spin-offs and is involved in founding companies. The Akademie der Gesundheit uses the campus labs to train professionals in the health sector.
Campus Berlin-Buch GmbH is the development and operating company of the Campus Berlin-Buch and partner for the establishment of enterprises and start-ups in the Biotech Park in Berlin-Buch.
"Drivers for Germany's Future Sustainability"
The UNIPRENEURS Initiative has recognized the entrepreneurial spirit of 20 professors, among them ECRC researcher Simone Spuler. As a co-founder of the startup MyoPax, she is pioneering stem cell tech...more ...
Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) increased its sales by 10% to € 118.0 million in the first half of 2023.more ...
Biosynth Expands Capabilities with Acquisition of celares, Experts in Bioconjugation and Specialty Polymers
Biosynth, a supplier of critical raw materials to the life science industry, is pleased to announce today that it has acquired celares, a leader in the development and manufacture of conjugate vaccine...more ...
Explore Precision Medicine Event im Futurium
Das Gläserne Labor beteiligt sich am 9. Oktober 2023 am Explore Precision Medicine Event im Futurium mit Workshops und Präsentationen.more ...